The Efficacy and Safety of IBI363 in Solid Tumors

Clinical trial NCT06081907 · RECRUITING

Trial details

NCT number: NCT06081907
Sponsor: Hunan Province Tumor Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-12-25
Primary completion: 2026-12-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.